Integra Lifesciences Holdings Corp (IART)
38.56
-0.16
(-0.41%)
USD |
NASDAQ |
Sep 22, 16:00
38.53
-0.03
(-0.08%)
After-Hours: 20:00
Integra Lifesciences Holdings Revenue (TTM): 1.545B for June 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 1.545B |
| March 31, 2023 | 1.562B |
| December 31, 2022 | 1.558B |
| September 30, 2022 | 1.565B |
| June 30, 2022 | 1.567B |
| March 31, 2022 | 1.559B |
| December 31, 2021 | 1.542B |
| September 30, 2021 | 1.526B |
| June 30, 2021 | 1.509B |
| March 31, 2021 | 1.378B |
| December 31, 2020 | 1.372B |
| September 30, 2020 | 1.378B |
| June 30, 2020 | 1.387B |
| March 31, 2020 | 1.512B |
| December 31, 2019 | 1.518B |
| September 30, 2019 | 1.506B |
| June 30, 2019 | 1.493B |
| March 31, 2019 | 1.475B |
| December 31, 2018 | 1.472B |
| September 30, 2018 | 1.458B |
| June 30, 2018 | 1.371B |
| March 31, 2018 | 1.287B |
| December 31, 2017 | 1.188B |
| September 30, 2017 | 1.075B |
| June 30, 2017 | 1.047B |
| Date | Value |
|---|---|
| March 31, 2017 | 1.014B |
| December 31, 2016 | 992.08M |
| September 30, 2016 | 977.57M |
| June 30, 2016 | 953.61M |
| March 31, 2016 | 916.97M |
| December 31, 2015 | 882.73M |
| September 30, 2015 | 860.65M |
| June 30, 2015 | 831.80M |
| March 31, 2015 | 850.48M |
| December 31, 2014 | 863.01M |
| September 30, 2014 | 725.32M |
| June 30, 2014 | 741.04M |
| March 31, 2014 | 715.24M |
| December 31, 2013 | 696.83M |
| September 30, 2013 | 829.88M |
| June 30, 2013 | 826.72M |
| March 31, 2013 | 831.34M |
| December 31, 2012 | 830.87M |
| September 30, 2012 | 819.96M |
| June 30, 2012 | 812.06M |
| March 31, 2012 | 795.22M |
| December 31, 2011 | 780.08M |
| September 30, 2011 | 770.69M |
| June 30, 2011 | 755.14M |
| March 31, 2011 | 740.41M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.372B
Minimum
Dec 2020
1.567B
Maximum
Jun 2022
1.494B
Average
1.511B
Median
Revenue (TTM) Benchmarks
| Haemonetics Corp | 1.219B |
| Abbott Laboratories | 40.23B |
| Boston Scientific Corp | 13.40B |
| Globus Medical Inc | 1.097B |
| Perspective Therapeutics Inc | 7.552M |